Recombinant Human Growth Hormone not checked

Changchun GeneScience Pharmaceutical Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
in China
Next date
Phase 4 trial completes
Trials
3 active
4 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“A single dose of 0.2 mg/day, administered once daily (QD) for 28 consecutive days.”In the company’s words, NCT07016802 on ClinicalTrials.gov
Tested for
Short Bowel Syndrome (SBS) in Adults, Pediatric Growth Hormone Deficiency, Safety, Tolerability, Adult Growth Hormone Deficiency
Main trialPhase 4
“This is a multicenter, open-label, single-arm clinical trial. A total of 100 participants with short bowel syndrome (SBS) receiving parenteral nutrition (PN) support are planned to be enrolled. The trial includes a 2-week run-in phase and a 4-week intervention phase, during which participants will receive rhGH injections. A safety follow-up period will then be conducted through Week 52.”In the company’s words, NCT07691125 on ClinicalTrials.gov
Other names
rhGH

Other drugs for Short Bowel Syndrome (SBS) in Adults

All 9 drugs for Short Bowel Syndrome (SBS) in Adults

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 4Recruiting 28 Apr 2027 Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome
Phase 1/2Recruiting Nov 2030 A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)
Phase 1Recruiting 25 Nov 2026 A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)
Phase 4Completed 25 Aug 2025 A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Recombinant Human Growth Hormone

Following is part of Solo: you see every change to Recombinant Human Growth Hormone the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in